IBC teleconference Oct 18 - Reminder
Join the conference Wednesday, October 18th between 9:30 p.m. and 11:00 p.m. Eastern Daylight Time (EDT)* (2:30 a.m. to 4:00 a.m. GMT October 19th), where Gabriel Hortobagyi, M.D., F.A.C.P., Thomas Buchholz, M.D., and Jennifer Sabol, M.D., F.A.C.S. will answer your questions about inflammatory breast cancer.
To join the conference, go to www.breastcancer.org any time between 9:30 p.m. and 11:00 p.m. EDT* on October 18th and click on the "Join Conference" button. No special software is required. A transcript of the conference will be posted on our site by October 27th.
__________________
Kate
Stage IIIC Diagnosed Oct 25, 2005 (age 58)
ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2%
Neoadjunct chemo: 4 A/C; 4 Taxatore
Bilateral mastectomy June 8, 2006
14 of 26 nodes positive
Herceptin June 22, 2006 - April 20, 2007
Radiation (X35) July 24-September 11, 2006
BRCA1/BRCA2 negative
Stage IV lung mets July 13, 2007 - TCH
Single brain met - August 6, 2007 -CyberKnife
Oct 2007 - clear brain MRI and lung mets shrinking.
March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra
|